Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP163927.RASrLRxsGr7-rJww2-P6NK-qvVayFcrEtw9ZLNxhHjlTQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP163927.RASrLRxsGr7-rJww2-P6NK-qvVayFcrEtw9ZLNxhHjlTQ130_assertion type Assertion NP163927.RASrLRxsGr7-rJww2-P6NK-qvVayFcrEtw9ZLNxhHjlTQ130_head.
- NP163927.RASrLRxsGr7-rJww2-P6NK-qvVayFcrEtw9ZLNxhHjlTQ130_assertion description "[The Groupe Francophone des (GFM) score segregated CMML patients into three risk groups based on: age >65 years, WBC >15?�?10?/L, anemia, platelets <100?�?10?/L, and ASXL1 mutation status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163927.RASrLRxsGr7-rJww2-P6NK-qvVayFcrEtw9ZLNxhHjlTQ130_provenance.
- NP163927.RASrLRxsGr7-rJww2-P6NK-qvVayFcrEtw9ZLNxhHjlTQ130_assertion evidence source_evidence_literature NP163927.RASrLRxsGr7-rJww2-P6NK-qvVayFcrEtw9ZLNxhHjlTQ130_provenance.
- NP163927.RASrLRxsGr7-rJww2-P6NK-qvVayFcrEtw9ZLNxhHjlTQ130_assertion SIO_000772 23963888 NP163927.RASrLRxsGr7-rJww2-P6NK-qvVayFcrEtw9ZLNxhHjlTQ130_provenance.
- NP163927.RASrLRxsGr7-rJww2-P6NK-qvVayFcrEtw9ZLNxhHjlTQ130_assertion wasDerivedFrom befree-20140225 NP163927.RASrLRxsGr7-rJww2-P6NK-qvVayFcrEtw9ZLNxhHjlTQ130_provenance.
- NP163927.RASrLRxsGr7-rJww2-P6NK-qvVayFcrEtw9ZLNxhHjlTQ130_assertion wasGeneratedBy ECO_0000203 NP163927.RASrLRxsGr7-rJww2-P6NK-qvVayFcrEtw9ZLNxhHjlTQ130_provenance.